New research continues to show that many people meet the criteria for obesity and associated health problems, even if their ...
New research reveals that one in five people with normal BMIs have hidden abdominal obesity, facing 29% higher blood pressure ...
Explore the truth behind the 'Freshman 15' myth and learn about the real factors contributing to weight changes in college ...
Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan ...
Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...
While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...
The U.S. adult obesity rate, calculated as having a BMI of 30 or higher, has gradually declined to 37% in 2025, dropping from a record high of 39.9% in 2022, according to a survey by the Gallup ...
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...
THE lure of the fat jab is clear to see, drastic weight loss fast – and seemingly without much effort. And the benefits ...
A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's ...
They peddle a deeper fantasy: that you can stop thinking about food at all. But their advice seems to have the opposite ...
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results